Mark Applebaum to Induction Chemotherapy
This is a "connection" page, showing publications Mark Applebaum has written about Induction Chemotherapy.
Connection Strength
0.217
-
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients. Pediatr Blood Cancer. 2020 10; 67(10):e28390.
Score: 0.169
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.048